Conmed (CNMD) Receivables (2010 - 2026)

Conmed's Receivables history runs 17 years deep, the most recent figure standing at $228.7 million for Q1 2026.

• Quarterly Receivables rose 3.4% year-over-year to $228.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $228.7 million (up 3.4% YoY) and the FY2025 annual result came in at $247.8 million, up 4.25% from the prior year.
• Receivables was $228.7 million for Q1 2026 at Conmed, down from $247.8 million in the prior quarter.
• Across five years, Receivables topped out at $247.8 million in Q4 2025 and bottomed at $183.2 million in Q1 2022.
• A 5-year average of $223.3 million and a median of $229.3 million in 2023 frame the typical range for Receivables.
• Annual changes were most pronounced in 2023 — Receivables advanced 26.62% — and 2025, when it retreated 8.42%.
• Conmed's Receivables stood at $191.3 million in 2022, then rose by 26.62% to $242.3 million in 2023, then decreased by 1.88% to $237.7 million in 2024, then advanced by 4.25% to $247.8 million in 2025, then dropped by 7.73% to $228.7 million in 2026.
• Business Quant data shows CNMD's Receivables at $228.7 million in Q1 2026, $247.8 million in Q4 2025, and $224.9 million in Q3 2025.